{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:06:42Z","timestamp":1790208402874,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002329","name":"Bundesamt f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"DOI":"10.1186\/s13756-025-01624-4","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:37:02Z","timestamp":1761046622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adherence to national recommendations for the control of multidrug-resistant microorganisms in Swiss acute care hospitals \u2013 an updated national survey"],"prefix":"10.1186","volume":"14","author":[{"given":"Andrea C.","family":"B\u00fcchler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliki","family":"Metsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Buetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Wolfensberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gottwalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Balmelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaud","family":"Catho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Jent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Sax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Senn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas F.","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tschudin-Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Harbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Vuichard-Gysin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for Swissnoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"1624_CR1","unstructured":"World Health Organization (WHO). Biggest Threats and Data [Internet]. 2020. Available from: https:\/\/www.cdc.gov\/drugresistance\/biggest-threats.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fdrugresistance%2Fbiggest_threats.html"},{"issue":"1","key":"1624_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini A, H\u00f6gberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56\u201366.","journal-title":"Lancet Infect Dis"},{"issue":"10325","key":"1624_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet"},{"key":"1624_CR4","unstructured":"Anresis - Swiss Centre for Antibiotic Resistance. https:\/\/www.anresis.ch\/antibiotic-resistance\/resistance-data-human-medicine\/. Resistance Data Human Medicine."},{"issue":"1","key":"1624_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-022-01052-8","volume":"11","author":"R Thoma","year":"2022","unstructured":"Thoma R, Seneghini M, Seiffert SN, Vuichard Gysin D, Scanferla G, Haller S, et al. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant acinetobacter baumannii outbreak and a systematic review of the literature. Antimicrob Resist Infect Control. 2022;11(1):1\u201311.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"48","key":"1624_CR6","doi-asserted-by":"publisher","first-page":"2200285","DOI":"10.2807\/1560-7917.ES.2022.27.48.2200285","volume":"27","author":"V Piezzi","year":"2022","unstructured":"Piezzi V, Wassilew N, Atkinson A, D\u2019Incau S, Kaspar T, Seth-Smith HMB, et al. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium (VRE) ST796, switzerland, 2017 to 2020. Eurosurveillance. 2022;27(48):2200285.","journal-title":"Eurosurveillance"},{"issue":"12","key":"1624_CR7","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1017\/ice.2023.125","volume":"44","author":"I Vock","year":"2023","unstructured":"Vock I, Aguilar-Bultet L, Goldenberger D, Ragozzino S, Kuster S, Tschudin-Sutter S. Epidemiology of patients harboring carbapenemase-producing bacteria and comparison with patients with detection of extended-spectrum beta-lactamase-producing Enterobacterales - A retrospective cohort study. Infect Control Hosp Epidemiol. 2023;44(12):1959\u201365.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"11","key":"1624_CR8","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.7326\/M21-2013","volume":"174","author":"EN Karmarkar","year":"2021","unstructured":"Karmarkar EN, O\u2019Donnell K, Prestel C, Forsberg K, Gade L, Jain S, et al. Rapid assessment and containment of Candida auris transmission in postacute care settings-orange county, california, 2019. Ann Intern Med. 2021;174(11):1554\u201362.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1624_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1086\/500624","volume":"27","author":"CD Salgado","year":"2006","unstructured":"Salgado CD, Farr BM. What proportion of hospital patients colonized with Methicillin-Resistant Staphylococcus aureus are identified by clinical Microbiological cultures?? Infect Control Hosp Epidemiol. 2006;27(2):116\u201321.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"1624_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13756-019-0479-5","volume":"8","author":"R Martischang","year":"2019","unstructured":"Martischang R, Buetti N, Balmelli C, Saam M, Widmer A, Harbarth S. Nation-wide survey of screening practices to detect carriers of multi-drug resistant organisms upon admission to Swiss healthcare institutions. Antimicrob Resist Infect Control. 2019;8(1):37.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1624_CR11","unstructured":"Vuichard-Gysin D, Senn L, Tschudin-Sutter S, Kuster S, Buetti N, Eder M et al. Pr\u00e4vention und Kontrolle von multiresistenten Erregern (MRE) im Nicht-Ausbruch-Setting [Internet]. 2021 [cited 2024 Apr 11]. Available from: https:\/\/www.swissnoso.ch\/fileadmin\/swissnoso\/Dokumente\/5_Forschung_und_Entwicklung\/8_Swissnoso_Publikationen\/211115_StAR_Teil_II_DE_MDRO-non-outbreak_FINAL.pdf"},{"key":"1624_CR12","doi-asserted-by":"crossref","unstructured":"Vuichard-Gysin D, Sommerstein R, Martischang R, Harbarth S, Kuster SP, Senn L et al. Candida auris - Recommendations on infection prevention and control measures in Switzerland. Swiss Med Wkly. 2020;150(39).","DOI":"10.4414\/smw.2020.20297"},{"key":"1624_CR13","unstructured":"Swissnoso. Empfehlungen zur Infektionspr\u00e4vention und-kontrolle bei Candida auris [Internet]. 2022 Jan [cited 2024 Sep 5]. Available from: https:\/\/swissnoso.ch\/fileadmin\/swissnoso\/Dokumente\/6_Guidelines_Publikationen_ab_Maerz_2023\/240326_C_auris_Empfehlungen_DE.pdf"},{"key":"1624_CR14","doi-asserted-by":"crossref","unstructured":"Finocchiaro Castro M, Lisi D, Romeo D. Experimental evidence on the role of shared protocols as coordination device on clinical best practices. Sci Rep. 2024;14(1).","DOI":"10.1038\/s41598-024-60186-4"},{"issue":"8","key":"1624_CR15","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ajic.2012.03.014","volume":"40","author":"M Pogorzelska","year":"2012","unstructured":"Pogorzelska M, Stone PW, Larson EL. Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: A National study. Am J Infect Control. 2012;40(8):696\u2013700.","journal-title":"Am J Infect Control"},{"key":"1624_CR16","unstructured":"Swissnoso FOPH. Structural minimum requirements for the prevention and control of healthcare-associated infections [Internet]. 2020 Sep [cited 2025 Aug 7]. Available from: https:\/\/www.swissnoso.ch\/fileadmin\/swissnoso\/Dokumente\/5_Forschung_und_Entwicklung\/8_Swissnoso_Publikationen\/Swissnoso_Minimalstandards_V3_D_220524.pdf"},{"key":"1624_CR17","unstructured":"Bundesamt f\u00fcr Gesundheit. Kennzahlen der Schweizer Spit\u00e4ler 2021 [Internet]. 2023. Available from: https:\/\/spitalstatistik.bagapps.ch\/data\/download\/kzp21_publication.pdf?v=1679384362"},{"key":"1624_CR18","doi-asserted-by":"publisher","unstructured":"M Bar Ilan, A Kjerulf. Who should be screened for carbapenemase-producingEnterobacterales and when? A systematic review. J Hosp Infect. 2023;142:74\u201387. Available from: https:\/\/doi.org\/10.1016\/j.jhin.2023.09.018Epub 2023 Oct 5.","DOI":"10.1016\/j.jhin.2023.09.018"},{"key":"1624_CR19","doi-asserted-by":"publisher","unstructured":"Lee BY, Bartsch SM, Hayden MK, Welling J, DePasse JV, Kemble SK et al. How Introducing a Registry With Automated Alerts for Carbapenem-resistant Enterobacteriaceae (CRE) May Help Control CRE Spread in a Region. Clinical Infectious Diseases [Internet]. 2020 Feb 14 [cited 2025 Jul 19];70(5):843\u20139. Available from: https:\/\/doi.org\/10.1093\/cid\/ciz300","DOI":"10.1093\/cid\/ciz300"},{"key":"1624_CR20","doi-asserted-by":"crossref","unstructured":"Bushuven S, Dettenkofer M, Dietz A, Bushuven S, Dierenbach P, Inthorn J et al. Interprofessional perceptions of emotional, social, and ethical effects of multidrug-resistant organisms: A qualitative study. PLoS One [Internet]. 2021 Feb 1 [cited 2025 Jul 19];16(2):e0246820. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0246820","DOI":"10.1371\/journal.pone.0246820"},{"key":"1624_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhin.2023.12.019","volume":"146","author":"SE Leonhard","year":"2024","unstructured":"Leonhard SE, Chong GM, Foudraine DE, Bode LGM, Croughs P, Popping S, et al. Proposal for a screening protocol for Candida auris colonization. J Hosp Infect. 2024;146:31\u20136.","journal-title":"J Hosp Infect"},{"key":"1624_CR22","unstructured":"Candida auris |. Candida auris (C. auris) | CDC [Internet]. [cited 2025 Aug 7]. Available from: https:\/\/www.cdc.gov\/candida-auris\/"},{"issue":"12","key":"1624_CR23","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.ajic.2018.05.025","volume":"46","author":"Z Copp\u00e9r\u00e9","year":"2018","unstructured":"Copp\u00e9r\u00e9 Z, Voiriot G, Blayau C, Gibelin A, Labbe V, Fulgencio JP, et al. Disparity of the screen-and-isolate policy for multidrug-resistant organisms: A National survey in French adult ICUs. Am J Infect Control. 2018;46(12):1322\u20138.","journal-title":"Am J Infect Control"},{"key":"1624_CR24","doi-asserted-by":"crossref","unstructured":"Gunnink LB, Arouri DJ, Jolink FEJ, Lokate M, de Jonge K, Kampmeier S et al. Compliance to Screening Protocols for Multidrug-Resistant Microorganisms at the Emergency Departments of Two Academic Hospitals in the Dutch\u2013German Cross-Border Region. Tropical Medicine and Infectious Disease. 2021, Vol 6, Page 15. 2021;6(1):15.","DOI":"10.3390\/tropicalmed6010015"},{"key":"1624_CR25","doi-asserted-by":"crossref","unstructured":"Lynch BL, Schaffer K. Can guidelines for the control of multi-drug-resistant Gram-negative organisms be put into practice? A National survey of guideline compliance and comparison of available guidelines. Journal of Hospital Infection. Volume 102. W.B. Saunders Ltd; 2019. pp. 1\u20137.","DOI":"10.1016\/j.jhin.2018.12.017"},{"issue":"5","key":"1624_CR26","doi-asserted-by":"publisher","first-page":"e027683","DOI":"10.1136\/bmjopen-2018-027683","volume":"9","author":"E Tacconelli","year":"2019","unstructured":"Tacconelli E, Buhl M, Humphreys H, Malek V, Presterl E, Rodriguez-Ba\u00f1o J, et al. Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe. BMJ Open. 2019;9(5):e027683.","journal-title":"BMJ Open"},{"issue":"1","key":"1624_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43058-021-00170-5","volume":"2","author":"CC Goedken","year":"2021","unstructured":"Goedken CC, Guihan M, Brown CR, Ramanathan S, Vivo A, Suda KJ, et al. Evaluation of carbapenem-resistant Enterobacteriaceae (CRE) guideline implementation in the veterans affairs medical centers using the consolidated framework for implementation research. Implement Sci Commun. 2021;2(1):1\u201314.","journal-title":"Implement Sci Commun"},{"key":"1624_CR28","unstructured":"Government of Western Australia D of H. Guidelines for the Screening and Management of Multi-resistant Organisms in Healthcare Facilities [Internet]. 2023 [cited 2024 Sep 30]. Available from: health.wa.gov.au."},{"key":"1624_CR29","unstructured":"Public Health England. Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris [Internet]. 2017 Aug [cited 2024 Sep 30]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/637685\/Updated_Candida_auris_Guidance_v2.pdf"},{"key":"1624_CR30","doi-asserted-by":"crossref","unstructured":"Alanio A, Snell HM, Cordier C, Desnos-Olivier M, Delli\u00e8re S, Aissaoui N et al. First Patient-to-Patient intrahospital transmission of clade I Candida auris in France revealed after a Two-Month incubation period. Microbiol Spectr. 2022;10(5).","DOI":"10.1128\/spectrum.01833-22"},{"key":"1624_CR31","unstructured":"World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities [Internet]. 2017. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259462\/9789241550178-eng.pdf;jsessionid=85DE4A4E4B8FC565277505A37E819ED9?sequence=1"},{"issue":"2","key":"1624_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1086\/338234","volume":"34","author":"EMC D\u2019Agata","year":"2002","unstructured":"D\u2019Agata EMC, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of Gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis. 2002;34(2):167\u201372.","journal-title":"Clin Infect Dis"},{"issue":"10 Supplement 2","key":"1624_CR33","first-page":"S165","volume":"35","author":"JD Siegel","year":"2006","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello R, the Healthcare Infection Control Practices Advisory Committee. Management of Multidrug-Resistant organisms in healthcare settings, 2006. Am J Infect Control. 2006;35(10 Supplement 2):S165\u201393.","journal-title":"Am J Infect Control"},{"key":"1624_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jhin.2023.06.013","volume":"139","author":"V Sch\u00e4rer","year":"2023","unstructured":"Sch\u00e4rer V, Meier MT, Schuepbach RA, Zinkernagel AS, Boumasmoud M, Chakrakodi B, et al. An intensive care unit outbreak with multi-drug-resistant Pseudomonas aeruginosa - spotlight on sinks. J Hosp Infect. 2023;139:161\u20137.","journal-title":"J Hosp Infect"},{"key":"1624_CR35","doi-asserted-by":"crossref","unstructured":"Catho G, Martischang R, Boroli F, Chra\u00efti MN, Martin Y, Koyluk Tomsuk Z et al. Outbreak of Pseudomonas aeruginosa producing VIM carbapenemase in an intensive care unit and its termination by implementation of waterless patient care. Crit Care. 2021;25(1).","DOI":"10.1186\/s13054-021-03726-y"},{"key":"1624_CR36","doi-asserted-by":"publisher","unstructured":"Jung J, Park JH, Yang H, Lim YJ, Kim EO, Lim CM et al. Active surveillance testing to reduce transmission of carbapenem-resistant, gram-negative bacteria in intensive care units: a pragmatic, randomized cross-over trial. Antimicrob Resist Infect Control [Internet]. 2023 Dec 1 [cited 2024 Jan 8];12(1):1\u20138. Available from: https:\/\/aricjournal.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13756-023-01222-2","DOI":"10.1186\/s13756-023-01222-2"},{"key":"1624_CR37","doi-asserted-by":"crossref","unstructured":"Geladari A, Karampatakis T, Antachopoulos C, Iosifidis E, Tsiatsiou O, Politi L et al. Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department. Transpl Infect Disease. 2017;19(3).","DOI":"10.1111\/tid.12686"},{"key":"1624_CR38","doi-asserted-by":"crossref","unstructured":"Ben-David D, Cohen Y, Levi G, Keren-Paz A, Tasher D, Zandman-Goddard G et al. Contribution of active surveillance cultures to the control of hospital-acquired carbapenem-resistant acinetobacter baumannii in an endemic hospital setting. Infect Control Hosp Epidemiol. 2023;1\u20138.","DOI":"10.1017\/ice.2023.162"},{"key":"1624_CR39","doi-asserted-by":"crossref","unstructured":"Giuffre M, Geraci DM, Bonura C, Saporito L, Graziano G, Insinga V et al. The increasing challenge of multidrug-resistant gram-negative bacilli: results of a 5-year active surveillance program in a neonatal intensive care unit. Med (United States). 2016;95(10).","DOI":"10.1097\/MD.0000000000003016"}],"container-title":["Antimicrobial Resistance & Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-025-01624-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:37:09Z","timestamp":1761046629000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01624-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1624"],"URL":"https:\/\/doi.org\/10.1186\/s13756-025-01624-4","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr Sarah Tschudin-Sutter serves as editor-in-chief for ARIC, and Dr Andreas Widmer serves as associated editor for ARIC. The authors have no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}